Provided by Tiger Trade Technology Pte. Ltd.

ANTENGENE-B

3.460
+0.0601.76%
Volume:632.50K
Turnover:2.19M
Market Cap:2.38B
PE:-7.79
High:3.535
Open:3.400
Low:3.400
Close:3.400
52wk High:6.930
52wk Low:2.760
Shares:687.00M
HK Float Shares:687.00M
Volume Ratio:0.75
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.444
ROE:6.39%
ROA:7.18%
PB:2.23
PE(LYR):-7.79
PS:3.60

Loading ...

Antengene Trims Share Capital Through 88,000-Share Buyback

Bulletin Express
·
Yesterday

ANTENGENE-B (06996) Spends HK$304,500 to Repurchase 88,000 Shares on September 30

Stock News
·
Yesterday

Antengene-B Executes Further Share Buyback, Adds 89.5K Shares to Treasury

Bulletin Express
·
Sep 29

Antengene Returns to Profit on Licensing Windfall; 1H 2026 Revenue Jumps to RMB 513.08 Million

Bulletin Express
·
Sep 29

Antengene Executes HK$0.30 Million Share Buyback, Lifting Treasury Stock to 2.42 Million Shares

Bulletin Express
·
Sep 28

Antengene-B (06996) Repurchases 90,000 Shares for HK$303,300 on September 28

Stock News
·
Sep 28

Antengene-B Repurchases 147,000 Shares, Outstanding Float Trimmed to 687.21 Million

Bulletin Express
·
Sep 25

ANTENGENE-B (06996) Spends HK$504,900 to Repurchase 147,000 Shares on September 25

Stock News
·
Sep 25

Antengene-B Spends HK$405,000 to Repurchase 117,500 Shares on September 24

Stock News
·
Sep 24

Antengene Repurchases 0.12 Million Shares at Average HKD 3.45; Treasury Stock Rises to 2.18 Million

Bulletin Express
·
Sep 24

Antengene Executes HKD 17,200 On-Exchange Share Buyback, Adds 5,000 Treasury Shares

Bulletin Express
·
Sep 21

Antengene-B Surges Over 9% as Pivotal Phase III CLINCH-3 Trial Completes First Patient Dosing

Stock News
·
Sep 21

Antengene Doses First Patient in Phase III Clinch-3 Trial of ATG-022 for Cldn18.2+ Gastric, GEJ Cancer

Reuters
·
Sep 21

Antengene Announces First Patient Dosed in Pivotal Phase Iii Clinch-3 Study of Atg-022

THOMSON REUTERS
·
Sep 21

ANTENGENE-B: THE CORE TRUST COMPANY LIMITED Acquires Shares, Long Position Rises to 10.84%

HK Disclosure
·
Sep 17

ANTENGENE-B: TCT (BVI) Limited Acquires Shares, Long Position Rises to 10.84%

HK Disclosure
·
Sep 17

ANTENGENE-B: Sheng Tang Acquires Shares via Off-Exchange Derivatives, Long Position Rises to 0.07%

HK Disclosure
·
Sep 16

ANTENGENE-B: Rafael Fonseca Acquires, Long Position Rises to 0.05%

HK Disclosure
·
Sep 16

ANTENGENE-B: Jing Qian Acquires, Long Position Rises to 0.07%

HK Disclosure
·
Sep 16

Antengene Publishes Preclinical Study of ATG-037 Plus Selinexor in Multiple Myeloma in Cancer Gene Therapy

Reuters
·
Sep 14